Breast Cancer Awareness Month
[New Webinar] In recognition of Breast Cancer Awareness Month, we unite to promote screening and prevention of breast cancer, which affects one in eight women…
[On-Demand Webinar] Liquid Biopsy in Oncology: Opportunities and Challenges
Join featured speakers from Medpace on September 8th, as they provide an overview of the current methodologies involved in liquid biopsies and their application for…
The Evolving Landscape of Therapeutic and Diagnostic Radiopharmaceuticals
In a new article, experts from Medpace’s radiation oncology, imaging, regulatory, and operational teams discuss the growing space of radiopharmaceutical development.
Blythe Thomson, MD, Rejoins Medpace Bringing New Experiences and Insights from a Sponsor’s Perspective
Medpace is pleased to announce that Dr. Blythe Thomson has rejoined Medpace’s Hematology and Oncology medical leadership team after spending several years holding a variety…
Medpace Core Laboratories is Pleased to Announce A Successfully Completed Inspection by the FDA
Medpace Core Laboratories successfully completed a comprehensive inspection by the FDA on a late phase, registrational, oncology trial. The inspection concluded with no major or…
Infectious Diseases in the Immunocompromised Host
An in-depth look at infectious diseases including hematologic malignancies in immunocompromised patients and the unique challenges for clinical development.
4 Key Considerations for Designing Immuno-Oncology Trials
As more agents approach the clinic, it is imperative for researchers to consider the design and conduct of immuno-oncology clinical trials. Given the diversity of…
Q&A: Dr. Gregory Hale Talks Exciting New Medical Innovations
Several weeks ago, we announced that Dr. Gregory Hale joined the Medpace medical leadership team. He is an experienced physician with clinical expertise in bone…